# BAIBYS Fertility

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/baibys-fertility

- Industry: Healthcare IT
- Headquarters: Tel-Aviv, Israel
- Website: www.baibys.com/
- Total disclosed funding: $4.5M
- Latest round: Series A (Jul 25, 2024)
- Investors on record: 2

## About

Founded in 2000 and based in Tel Aviv, Israel, BAIBYS Fertility Ltd. operates as a company that engages in AI and robotics-based sperm selection systems, advancing reproductive technology to support fertility solutions through scientific approaches. In July 2024, BAIBYS Fertility Ltd. raised USD 4.5 million in series A funding led by investor Firstime Ventures, with participation from another investor Rohto Pharmaceutical. Gal Golov, and Dr. Nino Guy Cassuto co-founded the firm. Dr. Yaron Silberman as CEO and Gal Golov as Co-CEO is leading the firm as of 2024.

Baibys provides an artificial intelligence-based robotic platform for sperm selection, which automates the process of classifying sperm morphology and motility at high magnification. The platform is fully autonomous, objective, and designed to select the spermatozoa for both IVF and ICSI (intracytoplasmic sperm injection).

## Funding rounds

- Series A, Jul 25, 2024, $4.5M — Firstime, Rohto Pharmaceutical

## Investors

- Firstime (https://capitalatlas.ai/funds/firstime) — Series A
- Rohto Pharmaceutical — Series A